Literature DB >> 11312341

Selective induction of apoptosis in antigen-presenting cells in mice by Parapoxvirus ovis.

N Kruse1, O Weber.   

Abstract

Viruses have evolved numerous mechanisms to avoid host immune reactions. Here we report a mechanism by which Parapoxvirus ovis (PPVO) interferes with antigen presentation. PPVO (orf virus) causes orf, an acute skin disease of sheep and goats worldwide. Importantly, PPVO can repeatedly infect its host in spite of a vigorous inflammatory and host immune response to the infection. We demonstrate in a mouse system that PPVO induces apoptosis in a significant number of antigen-presenting cells after intraperitoneal injection using the CD95 pathway, thus preventing a primary T-cell response. We also show that PPVO induces a compensatory activation of the immune system. Our results may help to explain the phenomenon that natural PPVO infections in sheep occur repeatedly even after short intervals. They also suggest that the combination of immunosuppressive and immunostimulatory mechanisms is an effective survival strategy that might be used in other viruses as well.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312341      PMCID: PMC114224          DOI: 10.1128/JVI.75.10.4699-4704.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  The microscopic appearance of ecthyma contagiosum (orf) in sheep, rabbits, and man.

Authors:  C E WHEELER; E P CAWLEY
Journal:  Am J Pathol       Date:  1956 May-Jun       Impact factor: 4.307

2.  [Experimental detection of the paraspecific effects of purified and inactivated poxviruses].

Authors:  A Mayr; M Büttner; G Wolf; H Meyer; C Czerny
Journal:  Zentralbl Veterinarmed B       Date:  1989-03

3.  Studies of the pathogenesis of orf virus infection in sheep.

Authors:  D J McKeever; D M Jenkinson; G Hutchison; H W Reid
Journal:  J Comp Pathol       Date:  1988-10       Impact factor: 1.311

Review 4.  Subversion of the immune system by pathogens.

Authors:  P Marrack; J Kappler
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Poxviral modifiers of cytokine responses to infection.

Authors:  D J Pickup
Journal:  Infect Agents Dis       Date:  1994 Apr-Jun

Review 6.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Highly attenuated poxviruses induce functional priming of neutrophils in vitro.

Authors:  R Förster; G Wolf; A Mayr
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.

Authors:  Y Ichihashi; S Matsumoto; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

9.  Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes.

Authors:  E Kass; J Parker; J Schlom; J W Greiner
Journal:  Cytokine       Date:  2000-07       Impact factor: 3.861

10.  Contagious ecthyma virus-vaccination failures.

Authors:  B M Buddle; R W Dellers; G G Schurig
Journal:  Am J Vet Res       Date:  1984-02       Impact factor: 1.156

View more
  9 in total

1.  Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.

Authors:  Jean-Luc Guerin; Jacqueline Gelfi; Severine Boullier; Maxence Delverdier; Frederique-Anne Bellanger; Stephane Bertagnoli; Ingo Drexler; Gerd Sutter; Frederique Messud-Petit
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis.

Authors:  Sabine Siegemund; Andrea Hartl; Heiner von Buttlar; Franziska Dautel; Rüdiger Raue; Marina A Freudenberg; György Fejer; Mathias Büttner; Gabriele Köhler; Carsten J Kirschning; Tim Sparwasser; Gottfried Alber
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

3.  Characterisation of parapoxviruses isolated from Norwegian semi-domesticated reindeer (Rangifer tarandus tarandus).

Authors:  Joern Klein; Morten Tryland
Journal:  Virol J       Date:  2005-09-05       Impact factor: 4.099

4.  Modulation of macrophage functions by sheeppox virus provides clues to understand interaction of the virus with host immune system.

Authors:  Abdel-Aziz S Abu-El-Saad; Ahmed S Abdel-Moneim
Journal:  Virol J       Date:  2005-03-22       Impact factor: 4.099

5.  AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Daniela Paulsen; Olaf Weber; Helga Ruebsamen-Schaeff; Bud C Tennant; Stephan Menne
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

6.  Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Kyle E Korolowicz; Manasa Suresh; Bin Li; Xu Huang; Changsuek Yon; Xuebing Leng; Bhaskar V Kallakury; Robin D Tucker; Stephan Menne
Journal:  Viruses       Date:  2021-04-09       Impact factor: 5.048

Review 7.  Therapeutic immunomodulation using a virus--the potential of inactivated orf virus.

Authors:  O Weber; A A Mercer; A Friebe; P Knolle; H-D Volk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-22       Impact factor: 5.103

8.  Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models.

Authors:  Daniela Paulsen; Andreas Urban; Andreas Knorr; Claudia Hirth-Dietrich; Angela Siegling; Hans-Dieter Volk; Andrew A Mercer; Andreas Limmer; Beatrix Schumak; Percy Knolle; Helga Ruebsamen-Schaeff; Olaf Weber
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 9.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.